Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NB1011 in TS-Overexpressing Cancers
NCT00248404Phase 2Completed
- Sponsor
- Kiadis Pharma
- Start
- Sep 2005
- Primary completion
- Dec 2007
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of thymectacin in solid tumor, sponsored by Kiadis Pharma. Started Sep 2005; status: completed.
02
Drugs
thymectacin
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT00248404.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00248404.